高盛：华润医药-2025 年中国医疗企业日要点总结：上半年在诸多挑战中实现温和增长。

更多资料加入知识星球：水木调研纪要 关注公众号：水木Alpha 29 June 2025 | 3:25PM HKT China Resources Pharmaceuticals (3320.HK): China Healthcare Corporate Day 2025 — Key Takeaways: Soft growth in 1H amid Presenter: Yulin Chen - Head of Investor Relations Bottom line: Management noted soft growth in 1H due to challenging industry environment and toned down previous guidance of double-digit y/y sales growth for 2025 pending recovery situation in 2H. Cash collection remained under pressure. Key Takeaways Soft growth in 1H: management to ...